Health Catalyst HCAT 深 滬
已收盤 08-07 16:00:00 美东时间
1.73
-0.580
-25.11%
華盛通- 最 高1.87
- 今 開1.855
- 成交量 305.13万股
- 最 低 1.66
- 昨 收 2.31
- 總市值 12.78万
- 52周最高 3.80
- 市盈率 靜 --
- 換手率 4129.33%
- 52周最低 0.9551
- 委 比 78.83%
- 總股本 7.39万
- 歷史最高 59.50
- 量 比 3.19
- 振 幅 9.09%
- 歷史最低 0.9551
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Health Catalyst Shares Tumble Overnight: What Investors Need to Know
Health Catalyst Inc. (NASDAQ:HCAT) shares fell 24.68% in Thursday’s overnight session after the company forecast a sharp sequential revenue decline for the third quarter despite topping its own second-quarter guidance. The stock closed Thursday’s regular session down 3.35% at $2.31 before falling an...
08-07 14:26
Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates.
Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates.
08-07 05:11
Health Catalyst Sells VitalWare, Refocuses Core Operations
Health Catalyst ( ($HCAT) ) has issued an announcement. On July 31, 2026, Healt...
08-07 04:58
Health Catalyst Sees Q3 Sales $55.000M-$56.000M vs $62.159M Est
Health Catalyst (NASDAQ:HCAT) sees Q3 sales of $55.000 million-$56.000 million vs $62.159 million analyst estimate.
08-07 04:09
Health Catalyst Q2 Adj. EPS $0.04 Beats $0.03 Estimate, Sales $70.487M Beat $69.059M Estimate
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $70.487 million which beat the analyst consensus estimate of $69...
08-07 04:04
Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
Health Catalyst, Inc. (Nasdaq: HCAT) will release its second quarter 2026 operating results on August 6, 2026, after market close, and host a conference call at 5:00 pm ET to review the results. U.S. participants can join by dialing 800-274-8461, while international participants can dial 203-518-9814, using conference ID “HCATQ226.” A live audio webcast will be available at https://ir.healthcatalyst.com/, with a replay accessible for 90 days post...
07-28 21:30
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Canaccord Genuity Maintains Buy on Health Catalyst, Raises Price Target to $3
Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and raises the price target from $2 to $3.
07-21 19:28
美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
富国银行维持Health Catalyst持股观望评级 将目标价上调至1.75美元
富国银行分析师斯坦·贝伦施泰因对Health Catalyst维持“持股观望”评级，将其目标价从1美元上调至1.75美元。 译文内容由第三方软件翻译。 声明：市...
06-27 03:19
